TAKANASHI KEN 4
4 · Wave Life Sciences Ltd. · Filed Aug 14, 2024
Insider Transaction Report
Form 4
TAKANASHI KEN
Director
Transactions
- Award
Ordinary Shares
2024-08-12+16,115→ 5,721,175 total - Award
Share Option (right to buy)
2024-08-12+32,230→ 32,230 totalExercise: $5.37Exp: 2029-08-12→ Ordinary Shares (32,230 underlying)
Footnotes (2)
- [F1]The reporting person was granted this restricted share unit award (RSU) pursuant to the 2024 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025.
- [F2]The reporting person was granted this option pursuant to the 2024 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025.